Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/26655
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVitaya Titapanten_US
dc.contributor.authorBanjob Indrasukhsrien_US
dc.contributor.authorViriya Lekpraserten_US
dc.contributor.authorWiroon Boonnuchen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-09-07T09:44:30Z-
dc.date.available2018-09-07T09:44:30Z-
dc.date.issued2001-12-01en_US
dc.identifier.citationJournal of the Medical Association of Thailand. Vol.84, No.10 (2001), 1395-1400en_US
dc.identifier.issn01252208en_US
dc.identifier.other2-s2.0-0035707410en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0035707410&origin=inwarden_US
dc.identifier.urihttp://repository.li.mahidol.ac.th/dspace/handle/123456789/26655-
dc.description.abstractThe safety and efficacy of Trihydroxyethylrutosides (HR) in the treatment of 53 patients with 1st-2nd degree hemorrhoids of pregnancy (16th-34th week) was investigated in a doubleblind randomised, placebo controlled trial. The dosage of Trihydroxyethylrutosides was 1 tablet of 300 milligrams twice daily for the first 2 weeks. If the treatment was successful, the treatment was stopped. If the clinical signs or symptoms still persisted, the treatment was continued for another two weeks using the same dosage and re-evaluated at the end of the fourth week after initial treatment. The parameters for efficacy were symptoms (pain, bleeding, exudation and pruritus) and the objective signs on proctoscopy (bleeding, inflammation and dilatation of the hemorrhoidal venous plexus). The study revealed improvement of symptoms in the study group which was better than in the control group after 2 weeks of treatment but the clinical signs were not different. After a further 2 weeks of treatment, the result showed improvement of both clinical signs and symptoms in this study. Only one mild transient side effect was reported in the HR group and there were no drug-related problems in the pregnancies, delivery or the babies.en_US
dc.rightsMahidol Universityen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0035707410&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleTrihydroxyethylrutosides in the treatment of hemorrhoids of pregnancy: A double-blind placebo-controlled trialen_US
dc.typeArticleen_US
dc.rights.holderSCOPUSen_US
Appears in Collections:Scopus 2001-2005

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.